An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of streptococcus pneumoniae in patients with acute exacerbation of chronic bronchitis.

Trial Profile

An open-label, randomized, multicenter, clinical study to compare the effects of telithromycin, azithromycin and cefuroxime axetil on the penicillin or macrolide resistance of streptococcus pneumoniae in patients with acute exacerbation of chronic bronchitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Azithromycin; Cefuroxime; Telithromycin
  • Indications Acute exacerbations of chronic bronchitis; Streptococcal infections
  • Focus Therapeutic Use
  • Acronyms PERSPECTIVE
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jun 2011 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
    • 17 Oct 2006 Status change
    • 13 Jan 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top